Ryan Fischesser, VP of Finance and Controller at Caribou Biosciences, Inc. (CRBU), bought 1,746 shares at $2.69 ($5K) on 2021-10-11, disclosed to the SEC on 2021-10-12.
Open-market purchase of $5k CRBU by VP of Finance and Controller. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| CRBU | BUY | 2021-12-21 | $3K | — | Filing → |